Remdesivir for the Treatment of Covid-19 - Final Report

John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline, Diego Lopez de Castilla, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Roger Paredes, Daniel A Sweeney, William R Short, Giota TouloumiDavid Chien Lye, Norio Ohmagari, Myoung-Don Oh, Guillermo M Ruiz-Palacios, Thomas Benfield, Gerd Fätkenheuer, Mark G Kortepeter, Robert L Atmar, C Buddy Creech, Jens Lundgren, Abdel G Babiker, Sarah Pett, James D Neaton, Timothy H Burgess, Tyler Bonnett, Michelle Green, Mat Makowski, Anu Osinusi, Seema Nayak, H Clifford Lane, ACTT-1 Study Group Members, Henrik Nielsen

Research output: Contribution to journalJournal articlepeer-review

2089 Citations (Scopus)
Original languageEnglish
JournalThe New England Journal of Medicine
Volume383
Issue number19
Pages (from-to)1813-1826
Number of pages14
ISSN0028-4793
DOIs
Publication statusPublished - 5 Nov 2020

Keywords

  • remdisivir
  • COVID-19

Fingerprint

Dive into the research topics of 'Remdesivir for the Treatment of Covid-19 - Final Report'. Together they form a unique fingerprint.
  • Remdisivir for Covid-19

    Nielsen, H.

    27/03/2020 → …

    Project: Research

Cite this